(Q34198763)

31 July 2017

title

Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane (English)

1 reference

31 July 2017

Netta Roz

1

1 reference

31 July 2017

Moshe Rehavi

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

31 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

31 July 2017

volume

73

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

461-470

1 reference

Activity profiles of two hyperforin-containing hypericum extracts in behavioral models

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

St. John's wort and depression: efficacy, safety and tolerability-an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hyperforin as a possible antidepressant component of hypericum extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

St. John's Wort, an anti-depressant? A systematic, criteria-based review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Inhibition of vesicular uptake of monoamines by hyperforin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

A molecular glimpse of vesicular monoamine transporters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Hypericum for depression. An update of the clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Role of Mg2+ion-activated ATPase and a pH gradient in the storage of catecholamines in synaptic vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Controlled clinical trials of hypericum extracts in depressed patients--an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900295-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(03)00295-9

1 reference

31 July 2017

1 reference